VOLITIONRX LTD — Director's Dealing 2021

Nov 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-11-01-05:00

Reporting Person: Plummer Nicholas (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-01-05:00	Common Stock	A	43500	—	Acquired	43500	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3500	Direct

Footnotes

F1: In connection with his employment as General Counsel of Volition Diagnostics UK Limited, Mr. Plummer received restricted stock units subject to a 2-year vesting schedule, vesting as to 21,750 units on each of 11/01/22 and 11/01/23, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.